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Abstract
Background: Obesity and overweight have been frequently observed in dogs and cats in recent years as in
humans. The compositions of fatty acids (FAs) in the accumulated lipids in tissues of obese animals may have
important roles in the process and mechanisms related to the onset of metabolic disorders. The purpose of this
study was to evaluate the effects of a high fat (HF) diet, which contained a higher proportion of saturated FAs, on
FA metabolism and distribution in obese cats.
Cats (N = 12) were divided into control diet group (crude fat; 16.0 %) (n = 4) or a high fat (HF) diet group (crude fat;
23.9 %) (n = 8). The HF diet contained up to 60 % of calories from fat and was rich in stearic acid. Blood samples
were collected at 0, 2, 4 and 6 weeks after the feeding. Adipose and liver tissues were collected at the 6th week
after feeding. We performed analysis of histological findings and fatty acid composition in serum and tissues.
Results: Body weights of the cats significantly increased in the HF group. The increased activities of hepatic
enzymes and the accumulation of lipid droplets were found in hepatocytes in the HF group at the 6th week
after feeding.
In this study, the stearic acid (C18:0)-rich HF diet contained less oleic acid (C18:1n-9) and more linoleic acid (C18:2n-6)
than the control. However, the composition of oleic acid in the liver was higher, and those of stearic acid and linoleic
acid were lower in the HF group at the 6th week after feeding. The higher oleic acid:stearic acid ratio suggests an
increase in the conversion from saturated FA to mono-unsaturated FAs, which may reflect the hepatic storage of FAs
as a relatively harmless form.
Conclusion: The stearic acid-rich HF diet increased hepatic lipid accumulation accompanied by the increased of
hepatic oleic acid, increased serum oleic acid and activation of hepatic enzymes. These findings could be an important
sign of early stages of dyslipidemia and hepatic damage. Also, the higher oleic acid:stearic acid ratio might be related
to the increased activity of SCD-1, which suggests that the stearic acid-rich HF diet evoked hepatic lipogenesis in the
feline liver.
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Background
Obesity and overweight have been frequently observed in
dogs and cats in recent years as in humans [1]. Obesity is
defined as ectopic lipid accumulation and is a risk factor
for metabolic disorders like diabetes, hyperlipidemia, and
hypertension in dogs and cats. The compositions of fatty
acids (FA) in the accumulated lipids of tissues of obese
animals may have important roles in the process and
mechanisms related to the onset of metabolic disorders;
however, the compositions of FAs are rarely analyzed in
the tissues of obese animals. The balance of saturated fatty
acids (SFA) and unsaturated fatty acids (UFA) is important
because of differences in the effects on FA metabolism and
tissue inflammation. For example, SFAs induce metabolic
disorders, whereas UFAs have the opposite effect [2, 3].
However, the increase of SFAs in plasma is associated with
low-grade inflammation in overweight adolescents, whereas
UFAs inhibit pro-inflammatory cytokine production in cells
and tissues [4].
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There are many similarities between feline and human
FA metabolism [5]. In both, FAs are absorbed from the
small intestine and are then transported as chylomicrons
into the blood. Conversely, endogenously synthesized
triglycerides (TG) and cholesterol comprise very low
density lipoproteins (VLDLs), and are delivered to per-
ipheral tissue and resolved into non-esterified fatty acids
(NEFA) by lipoprotein lipase when necessary. Excess
FAs are re-esterified and stored in the liver or adipose
tissue [6].
Dietary FA intake can affect the compositions of FAs
in the accumulated lipids of the body. FA imbalance
could increase inflammation mediators in the tissue and
blood. Consumption of a SFA-rich diet has been shown
to result in increased inflammation in adipose tissue by
regulating lymphocyte receptor signaling [7]. Also, re-
placement of a SFA-rich diet with UFA-rich diet could
decrease plasma inflammatory mediators in humans [8].
There are some similarities in metabolic changes follow-
ing obesity and diabetes between cats and humans [9].
Like in humans, changes in dietary FAs may be impli-
cated in the disordered lipid metabolism in cats. As yet,
there is little information concerning the effects of daily
FA compositions on fat metabolism and tissue inflam-
mation in cats.
The purpose of this study was to evaluate the effects
of a high fat (HF) diet on FA metabolism and distribu-
tion in cats. In this study, we conducted a controlled-
feeding trial in which we investigated the effects of a
short term feeding of a stearic acid (C18:0)-rich HF diet,
which contained a higher proportion of saturated FAs,
on the FA composition in the tissue (liver and adipose
tissue) and serum in healthy cats.
Methods
Animals and diet
The subjects for the experimental protocol were 12 female,
mixed-breed cats, which were clinically healthy and cared
for in accordance with the guidelines for the care and use
of laboratory animals approved by Nippon Veterinary and
Life Science University. The cats were divided into two
groups: control (n = 4) and HF group (n = 8). We divided
the cats into uneven in case they might refuse to eat the
experimental diet. The mean (± SD) age of the control
group was 10.0 ± 0.0 months and that of the HF group was
11.5 ± 6.7 months. The mean (± SD) body weight of the
control group was 2.4 ± 0.3 kg and that of the HF group
was 2.5 ± 0.3 kg. The control group was fed on a commer-
cial diet and the HF group was fed on the HF diet, which
was made to order1. The commercial diet consisted of fish
meal, skim milk, alfalfa, defatted soybean, wheat bran, beet
pulp, corn syrup, calcium carbonate, calcium phosphate,
salt, iron sulfate, manganese sulfate, zinc carbonate, copper
sulfate, vitamins A, D3, E, B1, B2, B6, K3, and B12, niacin,
calcium pantothenate, inositol, and folic acid. FA
composition of these diets is listed in Table 1. Dietary
fats derived from animal sources were used in this
study. The HF diet contained up to 60 % of calories
from fat; however, the total caloric intakes were same
as the control group. We used metabolizable energy
calculated with the following formula,
Metabolizable energy kcalð Þ
¼ Digestible energy kcalð Þ – 0:77  g proteinð Þ
The animal room was maintained at 24 ± 2 °C and at
55 ± 10 % relative humidity on a 12:12 h light:dark cycle
(lights on 8:00 AM to 8:00 PM). The cats were housed
in individual cages and fed once a day (morning), with
water ad libitum. Both groups were fed on their foods
ad libitum for their daily energy requirement (DER)
from 9:00 AM to 8:30 AM of the next day. Then, we re-
corded their food intake. The cats had no access to food
for 18 h prior to tests, but free access to water.
Body weight measurements and blood sample collec-
tions were repeated at 0, 2, 4 and 6 weeks after feeding.
Adipose and liver tissues were collected at the 6th week
after feeding. The above operations were performed at
10:00 AM after fasting for 18 h and blood samples were
taken from jugular veins.
Blood sampling and analysis
Peripheral blood was collected into heparinized tubes
and serum separation tubes and centrifuged at 1500 × g
for 10 min; the obtained plasma and serum were stored
at −30 °C until use. The plasma biochemical parameters
were analyzed using an autoanalyzer2. Serum was used
for analysis of total FAs and NEFAs with GC/MS.
Table 1 Composition of nutrients and FA composition in
control and HF diets
Control HF diet
Composition Moisture (%) 5.5 7.0
Crude protein (%) 33.6 32.7
Crude fat (%) 16.0 23.9
Crude fiber (%) 3.5 0.9
Crude ash (%) 5.8 6.8
Nitrogen free extract (%) 35.9 29.9
Kcal/g 4.2 4.7
Composition of FAs C16:0 (%) 35.2 35.5
C16:1 (%) 7.0 4.9
C18:0 (%) 14.4 25.0
C18:1n-9 (%) 34.8 27.6
C18:2n-6 (%) 5.7 5.0
C20:4n-6 (%) 2.9 2.0
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Tissue sampling and analysis
The liver, abdominal and subcutaneous adipose tissues
were collected at biopsy through a laparoscope. Under
anesthesia with propofol, cats underwent a laparoscopic
liver biopsy. The liver parenchyma (approximately
5 mm) was cut along the quadrate, right and left medial
lobes. At the same time, visceral adipose tissue was
obtained from the abdominal cavity and subcutaneous
adipose tissues from the inguinal region. Collected tis-
sues were immediately frozen in liquid nitrogen and
stored at −30 °C until use. After being freeze-dried, the
tissue samples were homogenized and were methylated
for the analysis of total FAs.
Methylation of total FAs in tissue and serum
Total FAs were methylated and extracted using a com-
mercial kit3. Dried serum or tissue was incubated with
0.5 mL of reagent A (toluene 52 %, methanol 48 %) and
0.5 mL of reagent B (methanol 93 %) at 37 °C for
60 min. Then, the mixture was kept at 37 °C for 20 min
after adding 0.5 mL of reagent C (methanol 30 %). After-
wards, 1.0 mL of extraction reagent (n-hexane 96 %) was
added to each sample and mixed vigorously and the
upper layer was collected. The upper layer was
washed with distilled water and injected into washed
silica-gel cartridges. After 3.0 mL of wash solvent
(n-hexane 96 %) was added, 3.0 mL of an eluting
solvent (n-hexane 96 %, methyl acetate 2 %) was
added to elute the FA methyl esters.
Methylation of NEFAs in serum
After 100 μL of chloroform and 0.1 mM NaOH were
added to serum and mixed to extract the NEFA fraction,
the upper layer was collected. The collected layer was
mixed with an equivalent amount of 0.1 mM HCL for
neutralization. A 0.5-mL aliquot of a mixture of chloro-
form–methanol–water (1:2.5:1, v/v/v) and heptadecanoic
acid (C17:0) as internal standard were added to the sample
and incubated at 37 °C for 60 min with shaking. Subse-
quently each sample was centrifuged at 1500 × g at 4 °C
for 3 min and 50 μL of the lower layer was transferred to
a 1.5-mL centrifuge tube. The sample was concentrated to
dryness in an evaporator for 30 min. Then the samples
were completely dried in a desiccator and derivatized by
adding 100 μL of 3 % hydrochloric-methanol at 30 °C for
2 h. Samples were dried again under nitrogen gas, and
then 200 μL of hexane was added.
FA composition with GC/MS analysis
Analysis of FA composition was performed using a GC/
MS system4. A DB-5 MS capillary column (30 m ×
0.25 mm× 0.25 μm5) was used to analyze derivatized sam-
ples. Helium was used as the carrier gas at 1.0 mL/min. An
injection volume of 1 μL was used and the injector and
source temperature was 280 °C. The column oven
temperature was programmed from 40 to 320 °C at 6 °C/
min and held at 40 and 320 °C for 2 and 1 min, respect-
ively. To detect and eliminate retention time shifts, a
standard alkane series mixture (C-10 to C-40) was injected
periodically into the GC/MS systems. Retention time cor-
rection of peaks based on retention time of the standard
alkane series mixture was performed using the AART
(Automatic Adjustment of Retention Time) function of
the GC/MS solution software (Shimadzu, Milan, Italy).
Chromatogram acquisition and compound identification
by a mass spectral library search were performed using the
Shimadzu GC/MS solution software.
Histological observation of livers of animals
A small amount of liver was taken from anaesthetized
animals by laparotomy and fixed in 10 % buffered forma-
lin and embedded in paraffin. Sections of livers were
stained with hematoxylin and eosin, and with oil red O
to investigate lipid accumulation in livers.
Statistics
Statistical analysis of the data was performed with
GraphPad Prism software version 5. The data are
expressed as means ± SD. Statistical processing was per-
formed for the transition of the total FA and NEFA con-
centrations and biochemical parameters with two-way
ANOVA, followed by the Bonferroni post hoc tests.
Differences between groups were considered significant
at P < 0.05.
Results
We recorded the food consumption data (Fig. 1). There
was no difference in food intake between the two groups.
Clinical findings
Body weights of the cats significantly increased in the
HF group (from 2.6 ± 0.3 to 3.2 ± 0.5 kg; P < 0.01),
whereas it did not change in the control group (from
2.5 ± 0.3 to 2.7 ± 0.3 kg). The plasma concentrations of
Fig. 1 Average weekly food consumption of cats. Open bars:
Control, Closed bars: High fat group
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aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT) activities and glucose concentrations in-
creased significantly in the HF group at the 6th week
after feeding (P < 0.05, Table 2). In the histological obser-
vations, the accumulation of lipid droplets was found in
hepatocytes in the HF group (Fig. 2).
FA composition in total FAs in liver
The hepatic FA composition at the 6th week after feeding
was different between the groups (Table 3). The com-
position of oleic acid (C18:1n-9) [% of total FA] was
higher (27.9 ± 3.3 % vs. 13.0 ± 0.2 %), and those of stearic
acid (C18:0) and linoleic acid (C18:2n-6) [% of total FA]
were lower in the HF group (13.2 ± 0.1 % vs. 20.5 ±
3.74 %; 31.5 ± 1.6 % vs. 39.2 ± 1.9 %, respectively).
FA composition in serum total FAs and NEFAs
The composition of oleic acid (C18:1n-9) [% of total FA]
in serum total FAs in the HF group increased from the
2nd week after feeding (P < 0.01). The linoleic acid
(C18:2n-6) composition [% of total FA] in serum total
FAs decreased (P < 0.05) and that of arachidonic acid
(C20:4n-6) tended to decrease from the 2nd week after
feeding (Table 4). In terms of the compositions between
the two groups, the component of oleic acid was signifi-
cantly greater (P < 0.05, P < 0.01), whereas that of linoleic
acid was significantly lower (P < 0.05, P < 0.01) in HF
group at the 4th and 6th week, respectively, after feeding.
Arachidonic acid was significantly greater only at the 6th
week (P < 0.01, Table 4). In terms of the FA composition
of serum NEFAs, the linoleic acid and arachidonic acid
compositions [% of total NEFA] decreased in the HF
group after feeding (Table 5). However, compositions of
palmitic acid (C16:0) and oleic acid [% of total FA]
increased at the 6th week after feeding.
FA composition in total FAs in adipose tissue
The FA composition in total FAs in adipose tissue at the
6th week after feeding was not different between groups.
Additionally, there was no difference in FA composition
between abdominal and subcutaneous fat (Table 6).
Discussion
The histological findings showed lipid accumulation,
which mainly consisted of TGs, in hepatocytes from the
HF group. When hepatic FA oxidation is less than its in-
flux, FAs may be accumulated or elongated [10]. These
results were consistent with the study, which showed
Table 2 Changes in plasma biochemical parameters in cats fed a control or HF diet for 6 weeks
Pre 2 weeks 4 weeks 6 weeks
Cont (n = 4) TP (g/dl) 6.5 ± 0.4 6.4 ± 0.7 6.7 ± 6.8* 7.0 ± 0.5*
AST (IU/l) 26.5 ± 1.7 32.5 ± 3.7 29.0 ± 1.7 30.0 ± 1.8
TG (mg/dl) 44.1 ± 17.3 49.5 ± 3.5 38.4 ± 7.0 50.0 ± 10.0
ALT (IU/l) 52.0 ± 11.9 61.5 ± 5.7 65.0 ± 13.5 57.0 ± 11.4
ALP (IU/l) 96.5 ± 29.4 170.0 ± 62.5**A 114.5 ± 33.5A 119.0 ± 40.3
LDH (IU/l) 107.0 ± 25.3 116.5 ± 12.5 109.5 ± 80.0 112.0 ± 40.7
T-cho (mg/dl) 106.0 ± 8.8 99.5 ± 8.0 116.0 ± 11.9 104.5 ± 8.7
Glu (mg/dl) 76.5 ± 6.5 79.5 ± 3.9 79.5 ± 26.3 77.0 ± 1.3
BUN (mg/dl) 23.5 ± 1.3 22.5 ± 1.7 22.5 ± 1.5 22.5 ± 1.7
Crea (mg/dl) 0.7 ± 0.1 0.9 ± 0.2 0.9 ± 0.1 0.9 ± 0.1
NEFA (mEq/L) 0.4 ± 0.0 0.5 ± 0.0 0.3 ± 0.1 0.5 ± 0.4*
HF (n = 8) TP (g/dl) 6.5 ± 0.6 6.4 ± 0.6 6.5 ± 0.5 6.7 ± 0.5
AST (IU/l) 27.5 ± 4.5 30.5 ± 6.4* 31.5 ± 5.6* 32.0 ± 4.5**
TG (mg/dl) 44.1 ± 15.5 40.3 ± 19.8 40.3 ± 7.5 32.4 ± 29.7
ALT (IU/l) 41.0 ± 14.2 59.5 ± 10.5 61.5 ± 12.7* 70.5 ± 12.4**
ALP (IU/l) 77.0 ± 50.6 200.0 ± 16.2**BC 112.0 ± 52.2B 109.5 ± 55.0C
LDH (IU/l) 136.0 ± 46.3 122.0 ± 54.2 112.5 ± 46.4 126.5 ± 68.3
T-cho (mg/dl) 104.0 ± 20.2 93.5 ± 21.4** 98.0 ± 17.5 103.0 ± 29.1
Glu (mg/dl) 73.0 ± 5.7 81.0 ± 7.8 84.5 ± 15.1** 76.0 ± 10.6
BUN (mg/dl) 23.5 ± 3.8 22.5 ± 2.2 23.5 ± 2.5 22.5 ± 2.3**
Crea (mg/dl) 0.8 ± 0.3 0.9 ± 0.2 1.0 ± 0.2 1.1 ± 0.2**
NEFA (mEq/L) 0.4 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 0.6 ± 0.2*
Significantly different from Pre: *; P < 0.05 **; P < 0.01. The same capital letters indicate statistically significant differences between the time points (P < 0.05)
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that HF feeding induced the accumulation of hepatic TGs
without causing blood TG levels to increase in mice [11].
Though there is a report in which increased caloric intake
caused fat storage in the feline liver [12], there are no stud-
ies about the effects of a high-fat diet on hepatic steatosis in
cats. The plasma biochemical analysis showed significant
increases in AST and ALT activity levels in the HF group
after feeding in this study. Felines with hepatic lipidosis
have been shown to have significantly higher activity levels
of ALT and AST in the plasma [13]. Increased ALT and
AST activity levels are one of the most common indicators
of liver damage. These findings suggested that HF feeding
triggered an early stage of hepatic lipidosis and damage in
the cats. Also, the increased serum adiponectin concentra-
tions in cats with hepatic lipidosis could be related to hep-
atic damage, may be the result of hepatic resistance to
adiponectin [14]. Adiponectin is most abundantly produced
by adipose tissue [15] and increases fat combustion and
Fig. 2 Histology of livers of cats after feeding. Hematoxylin and eosin (HE) staining of livers from the control group (a) and HF group (b). Oil red
O staining of livers (c and d) revealed the accumulation of lipid droplets in hepatocytes in the HF group. Cells in Fig. 2a appeared to have greater
steatosis than cells in Fig. 2b
Table 3 FA composition in serum total FAs of cats fed a control or HF diet for 6 weeks
Pre 2 week 4 week 6 week
(%) (%) (%) (%)
Control (n = 4) C16:0 10.7 ± 1.1 9.5 ± 0.9 9.8 ± 1.1 10.5 ± 0.6
C16:1n-7 6.6 ± 1.3 7.3 ± 0.3 7.1 ± 0.5 7.2 ± 0.4
C18:0 14.8 ± 0.9 16.1 ± 1.3 15.6 ± 1.1 14.5 ± 0.3a
C18:1n-9 20.6 ± 3.2 20.8 ± 3.1 20.0 ± 2.4b 19.8 ± 0.8c
C18:2n-6 38.6 ± 2.3 38.5 ± 3.1 39.4 ± 4.2d 40.5 ± 1.4e
C20:4n-6 7.7 ± 0.3 7.3 ± 0.8 8.5 ± 2.1 6.7 ± 0.7f
HF (n = 8) C16:0 10.5 ± 0.6 10.1 ± 0.8 10.2 ± 0.8 10.8 ± 1.1
C16:1n-7 5.9 ± 1.4 7.7 ± 2.7 6.4 ± 2.0 6.4 ± 1.7
C18:0 14.7 ± 1.0 14.9 ± 1.1 15.5 ± 0.7 15.5 ± 0.9*a
C18:1n-9 18.8 ± 2.0 28.1 ± 3.4** 25.1 ± 1.0**b 24.6 ± 1.6**c
C18:2n-6 34.4 ± 3.8 31.3 ± 4.7* 32.0 ± 2.9*d 31.0 ± 2.8**e
C20:4n-6 12.2 ± 4.6 8.7 ± 1.4** 11.2 ± 1.6 10.5 ± 2.0f
Significantly different from Pre: *; P < 0.05 **; P < 0.01. The same lowercase letters indicate statistically significant differences between the two groups (P < 0.05)
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energy consumption. When the sensitivity to adiponectin is
reduced, it may lead to fat accumulation.
In this study, an increased composition of oleic acid
and decreased stearic acid was observed after feeding in
the HF group. These results are in agreement with re-
ports that SFA and monounsaturated fatty acids
(MUFAs) increased in cats with idiopathic fatty liver and
humans with nonalcoholic fatty liver disease or diabetes
[16–18] The major sources of FAs for hepatic TGs were
chylomicron remnants from dietary fat, derivation from
adipose tissue, and de novo synthesis from the liver [13].
In this study, the stearic acid-rich HF diet contained less
oleic acid and more linoleic acid than the control, which
did not correlate with the hepatic accumulated FA com-
position in the HF group. Also, there were different con-
tents of FAs in the liver and adipose tissue of the HF
group after feeding. These results did not support the
hypothesis that the origin of increased oleic acid accu-
mulation in the liver was derived from the chylomicron
remnants from dietary fat or mobilization from adipose
tissue. The higher oleic acid:stearic acid ratio could be
related to the increased activity of Δ9 desaturase (SCD-1),
which catalyzes the conversion of palmitic acid (16:0) and
stearic acid (18:0) into palmitoleic (16:1n-7) and oleic acid
[19]. SCD-1 activity was reported to increase with
increasing liver fat contents [20]. It has been thought that
little lipogenesis occurred in the feline liver [17]. However,
the increase of oleic acid, one of the major products of
lipogenesis, suggested that the stearic acid-rich HF
diet evoked hepatic lipogenesis in the cats. SCD-1 has
a protective effect against SFAs lipotoxicity by enhan-
cing conversion of dietary SFAs to MUFAs [21]. In
this study, the increase in conversion from SFAs to
MUFAs may reflect the hepatic safe storage of FAs as
a relatively harmless form.
In this study, the FA composition of hepatic and
serum FA showed greater percentages of oleic acid and
lesser percentages of linoleic acid. In fasting serum, most
of the TGs were contained in VLDL and its proportion
changed along with increasing adiposity. Actually, it was
reported that VLDL contained 30 % of TGs in lean cats,
whereas it was increased to 70 % in obese cats [22]. An-
other study about feline hepatic lipidosis showed that
VLDL assembly and secretion were increased with hepatic
lipidosis [23]. Also, it was thought that increased oleic acid
in NEFAs also stimulate hepatic VLDL production [24]. In
the present study, we did not perform an analysis of
changes in lipoproteins. However, considering the similar-
ities between the FA composition of the serum and liver, it
was suggested that changes in the composition of serum
FAs could be reflected by the FAs in the VLDL. To clarify
these etiologies, further study is needed to investigate the
amount and composition of the VLDL-TGs. Another
trend, the changes in the composition of total FAs in
serum, was in parallel with those of NEFAs. It was re-
ported that only 4–7 % of plasma NEFAs are directed to-
ward VLDL-TGs under post-absorptive conditions in
healthy men and women [25, 26]. However, in over-
weight/obese man, it is thought that hepatic FA oxidation
was decreased, which diverted twice the amount of NEFAs
(15 %) toward hepatic VLDL-TG esterification and
Table 4 Changes in FA composition in total FAs in the liver of
cats fed a control or HF diet
Control (n = 2) HF (n = 2)
C16:0 (%) 11.5 ± 1.5 13.8 ± 1.0
C16:1n-7 (%) 2.0 ± 0.1 1.4 ± 0.1
C18:0 (%) 20.5 ± 3.7 13.2 ± 0.1
C18:1n-9 (%) 13 ± 0.2 27.9 ± 3.3
C18:2n-6 (%) 39.2 ± 1.9 31.5 ± 1.6
C20:4n-6 (%) 13.8 ± 0.4 12.2 ± 0.7
Table 5 Changes in FA composition in NEFAs in the serum of cats fed a control or HF diet
Pre 2 weeks 4 weeks 6 weeks
(%) (%) (%) (%)
Control (n = 4) C16:0 21.0 ± 1.0 20.0 ± 2.8 20.9 ± 1.8 21.5 ± 2.7
C18:0 37.8 ± 1.6 32.9 ± 5.4 36.4 ± 2.3 39.8 ± 4.5
C18:1n-9 5.8 ± 0.4 5.7 ± 0.6a 4.9 ± 0.5 4.8 ± 0.5b
C18:2n-6 32.9 ± 0.9 39.4 ± 2.6** 35.5 ± 1.0c 32.7 ± 2.7
C20:4n-6 2.1 ± 0.3 1.6 ± 0.2 1.4 ± 0.3 1.1 ± 0.6
HF (n = 8) C16:0 20.0 ± 2.5 18.8 ± 2.0AB 22.8 ± 2.8A 22.7 ± 5.2*B
C18:0 34.3 ± 2.2 37.4 ± 5.10 43.0 ± 3.1* 36.5 ± 8.7
C18:1n-9 6.0 ± 0.6 8.7 ± 1.8**Ca 5.8 ± 1.1CD 8.2 ± 1.5**Db
C18:2n-6 37.0 ± 2.1 33.8 ± 5.0 E 28.3 ± 3.7**Ec 30.2 ± 6.1**
C20:4n-6 2.6 ± 1.0 1.7 ± 0.5** 1.6 ± 0.5** 1.8 ± 0.8**
Significantly different from Pre: *; P < 0.05 **; P < 0.01. The same capital letters indicate statistically significant differences between the time points (P < 0.05). The
same lowercase letters indicate statistically significant differences between the two groups (P < 0.05)
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secretion [27]. Thus, the changes in serum NEFA compos-
ition could reflect the VLDL composition in the HF group
cats. In this study, the exact mechanisms regarding the
change in NEFA composition were not clear. The majority
of plasma NEFAs was remobilized from adipose tissue by
hormone-sensitive TG lipase activation [28]. However, the
different contents of the FAs in plasma NEFAs and adi-
pose tissue did not support the hypothesis that NEFAs were
mobilized from adipose tissue in this study. Further analysis
may be necessary that include examining the relationship
between the origin of NEFAs and VLDL composition.
Limitation
There are some limitations in this study related to the di-
ets and the sampling of tissues. First, the control diet con-
tained higher amounts of fiber. This might have an effect
on the efficiency of fat absorption in the intestine. The
contents of C16:1, C18:1n-9, C18:2n-6, and C20:4n-6 in
the HF diet were decreased compared with the control
diet to create a higher ratio of stearic acid. Second, the tis-
sue samples were obtained from only two cats per dietary
treatment group.
Conclusion
A stearic acid-rich HF diet increased hepatic lipid accu-
mulation accompanied by the increased ratio of hepatic
oleic acid, increased serum oleic acid, and activation of
hepatic enzymes. These findings could be an important
sign of early stages of dyslipidemia and hepatic damage.
Also, the higher ratio of oleic acid:stearic acid might be re-
lated to the increased activity of SCD-1, which suggests
that a stearic acid-rich HF diet evoked hepatic lipogenesis
in the feline liver.
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